13F-HR filed by Aquilo Capital Management, LLC
Aquilo Capital Management, LLC filed this 13F-HR for the quarter ended 2022-12-31, filed 2023-02-14, with 13 holding rows worth $266,215,570.
- Accession
- 0001591986-23-000005
- Filer
- CIK 1591986
- Filed
- 2023-02-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q4 2022
A holdings report, 13 entries on the cover page, a total value of $266,215,570 stated on the cover page (in dollars after the unit check, H1), rows summing to $266,215,570 with VALUE read as dollars as filed, 13F file number 028-18892. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| ARROWHEAD PHARMACEUTICALS IN | 04280A100 | COM | 1,103,515 | $44,758,568 | dollars as filed | |
| SPDR SER TR | 78464A870 | S&P BIOTECH | 500,000 | $41,500,000 | dollars as filed | put |
| BLUEPRINT MEDICINES CORP | 09627Y109 | COM | 581,768 | $25,487,256 | dollars as filed | |
| ARVINAS INC | 04335A105 | COM | 673,941 | $23,055,522 | dollars as filed | |
| MERUS N V | N5749R100 | COM | 1,432,109 | $22,154,726 | dollars as filed | |
| REGENXBIO INC | 75901B107 | COM | 897,684 | $20,359,473 | dollars as filed | |
| SILENCE THERAPEUTICS PLC | 82686Q101 | ADS | 1,284,133 | $19,583,028 | dollars as filed | |
| KYMERA THERAPEUTICS INC | 501575104 | COM | 629,411 | $15,710,099 | dollars as filed | |
| AMRYT PHARMA LTD - SPNR ADR | 03217L106 | COMMON EQUITY | 2,098,993 | $15,322,649 | dollars as filed | |
| UNIQURE NV | N90064101 | SHS | 624,854 | $14,165,440 | dollars as filed | |
| GENMAB A/S | 372303206 | Ordinary Shares, nominal value DKK 1 per share | 242,848 | $10,291,898 | dollars as filed | |
| ARGENX SE SPONSORED ADR | 04016X101 | ADR | 24,000 | $9,091,920 | dollars as filed | |
| PIERIS PHARMACEUTICALS INC | 720795103 | COM | 4,552,876 | $4,734,991 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001591986-23-000005 | this filing | 2023-02-14 | acceptance time not in the bulk data set |